Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Sodium chloride; Potassium chloride; Calcium chloride dihydrate
Baxter Holding B.V.
B05BB; B05BB01
Sodium chloride; Potassium chloride; Calcium chloride dihydrate
0 milligram(s)/litre
Solution for infusion
Product subject to prescription which may not be renewed (A)
Solutions affecting the electrolyte balance; electrolytes
Marketed
2003-07-11
PACKAGE LEAFLET: INFORMATION FOR THE USER RINGER’S SOLUTION FOR INFUSION Active substances: sodium chloride, potassium chloride and calcium chloride dihydrate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or nurse. • If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET: 1. What Ringer’s Solution for Infusion is and what it is used for 2. What you need to know before you are given Ringer’s Solution for Infusion 3. How you will be given Ringer’s Solution for Infusion 4. Possible side effects 5. How to store Ringer’s Solution for Infusion 6. Contents of the pack and other information 1. WHAT RINGER’S SOLUTION FOR INFUSION IS AND WHAT IT IS USED FOR Ringer’s Solution for Infusion is a solution of the following substances in water: • sodium chloride • potassium chloride • calcium chloride dihydrate • Ringer’s Solution for Infusion is used to treat a loss of body water (dehydration) and chemicals (e.g. by heavy sweating, kidney disorders) 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN RINGER’S SOLUTION FOR INFUSION DO NOT RECEIVE RINGER’S SOLUTION FOR INFUSION IF YOU ARE SUFFERING FROM ANY OF THE FOLLOWING CONDITIONS • Preterm newborn infants and term newborn infants (≤28 days of age): Your child must not receive a certain antibiotic called ceftriaxone as a drip into a vein at the same time with this medicine • when there is too much fluid in the spaces around the cells of the body (extracellular hyperhydration) • when there is a larger volume of blood in the blood vessels than there should be (hypervolaemia) • severe kidney failure (when your kidneys do not work well and you require dialysis) • uncompensated heart failure. This is heart failure that is not adequately treated and causes symptoms such a Prečítajte si celý dokument
Health Products Regulatory Authority 10 January 2024 CRN00DVSL Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ringer’s Solution for Infusion, Viaflo container 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium chloride: 8.60 g/L Potassium chloride: 0.30 g/L Calcium chloride dihydrate: 0.33 g/L mmol/l: Na + : 147 K + : 4 Ca ++ : 2.25 Cl - : 155.50 mEq/l: Na + : 147 K + : 4 Ca ++ : 4.50 Cl - : 155.50 _For full list of excipients, see section 6.1._ 3 PHARMACEUTICAL FORM Solution for infusion. Clear solution, free from visible particles. Osmolarity: 309 mOsm/l (approx) pH: 5.0 to 7.5 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ringer’s Solution for Infusion is indicated to: - Replace extracellular fluid losses, - Restore the sodium, potassium, calcium and chloride balances, for treatment of isotonic dehydration 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults, the Elderly, Adolescents and Children_: Fluid balance, serum electrolytes and acid-base balance may need to be monitored before and during administration, with particular attention to serum sodium in patients with increased non-osmotic vasopressin release (syndrome of inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medicated with vasopressin agonist drugs, due to the risk of hospital acquired hyponatraemia (see sections 4.4, 4.5 and 4.8). Monitoring of serum sodium is particularly important for hypotonic fluids. Ringer's Solution tonicity: Isotonic solution The infusion rate and volume depend on the age, weight, clinical condition (e.g. burns, surgery, head-injury, infections), and concomitant therapy should be determined by the consulting physician experienced in paediatric intravenous fluid therapy (see sections 4.4. and 4.8). _Recommended dosage:_ The recommended dosage is: - for adults, the elderly and adolescents: 500 ml to 3 _litres_ /24h - for babies and children: 20 ml to 100 ml / kg / 24 h_._ _Administration rate:_ Health Products Regulatory Authority 10 January 2024 CRN00DVSL Prečítajte si celý dokument